» Articles » PMID: 27050111

The Cost of Vaccination Throughout Life: A Western European Overview

Overview
Date 2016 Apr 7
PMID 27050111
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Despite the interest of policy makers, the actual investment in vaccination is poorly documented. Our study assessed the costs of vaccination throughout life for a fully immunized Western European citizen. National vaccination calendars for England, France, Germany, Italy, Portugal, Spain and Sweden were retrieved. We differentiated men from women and healthy individuals from those suffering from underlying conditions who require specific additional vaccinations. Vaccine costs and administration fees were retrieved from official national source and calculated from the national healthcare perspective. Vaccinating an individual against up to 17 diseases throughout his entire life and in full compliance with national vaccination calendars cost between €328 and €2,352 (vaccines costs only) and between €443 and €3,395 (administration costs included), the lowest range corresponds to a healthy man in Sweden and the highest to a woman with underlying conditions in England. Vaccination costs varied among countries due to heterogeneous national vaccination calendars and organization. In all countries, adults (18-64 y) and elderly (≥65 y) accounted for the lowest vaccines costs compared with infants (0-24 m) and children/adolescents (2-17 y). In comparison, other mass secondary preventive therapies may be at least 3 times more costly. Vaccination requires a relatively low level of investment per individual. Our estimates should be considered to be the maximum potential costs due to our 100% compliance assumption. Increasing coverage rates would bring additional public health benefits for a relatively low incremental cost. A life-course approach of vaccination should also be encouraged because some missed opportunities remain in senior vaccinations.

Citing Articles

The impact of coronavirus disease 2019 (COVID-19) pandemic experiences on attitudes towards vaccinations: on the social, cultural and political determinants of preferred vaccination organization models in Poland.

Zuk P, Zuk P Health Res Policy Syst. 2024; 22(1):128.

PMID: 39300562 PMC: 11411984. DOI: 10.1186/s12961-024-01214-7.


[Updated cost of vaccinating throughout life in Spain in 2023].

Fernandez Conde S, Cifo Arcos D, Sanchez-Cambronero Cejudo L, Olmedo Luceron C, Fernandez Duenas A, Cantero Gudino E Rev Esp Salud Publica. 2024; 97.

PMID: 38205708 PMC: 11567089.


Prices of paediatric vaccines in European vaccination programmes.

Salo H, Sakalauskaite M, Levy-Bruhl D, Lindstrand A, Valentiner-Branth P, Wichmann O Vaccine X. 2023; 15:100392.

PMID: 37779660 PMC: 10539658. DOI: 10.1016/j.jvacx.2023.100392.


Public health impact and return on investment of Belgium's pediatric immunization program.

Carrico J, Mellott C, Talbird S, Bento-Abreu A, Merckx B, Vandenhaute J Front Public Health. 2023; 11:1032385.

PMID: 37427250 PMC: 10323141. DOI: 10.3389/fpubh.2023.1032385.


Trends in hospitalization and death rates among patients with head and neck cancer in Spain, 2009 to 2019.

Carazo-Casas C, Gil-Prieto R, Hernandez-Barrera V, de Miguel A Hum Vaccin Immunother. 2022; 18(5):2082192.

PMID: 35930449 PMC: 9621082. DOI: 10.1080/21645515.2022.2082192.


References
1.
Eilers R, Krabbe P, van Essen T, Suijkerbuijk A, van Lier A, de Melker H . Assessment of vaccine candidates for persons aged 50 and older: a review. BMC Geriatr. 2013; 13:32. PMC: 3668232. DOI: 10.1186/1471-2318-13-32. View

2.
Morano R, Perez F, Brosa M, Perez Escolano I . [Cost-effectiveness analysis of pneumococcal vaccination in Spain]. Gac Sanit. 2011; 25(4):267-73. DOI: 10.1016/j.gaceta.2011.03.006. View

3.
Johnson D, Nichol K, Lipczynski K . Barriers to adult immunization. Am J Med. 2008; 121(7 Suppl 2):S28-35. DOI: 10.1016/j.amjmed.2008.05.005. View

4.
Gellin B, Landry S . The value of vaccines: our nation's front line against infectious diseases. Clin Pharmacol Ther. 2010; 88(5):580-1. DOI: 10.1038/clpt.2010.197. View

5.
Largeron N, Levy P, Wasem J, Bresse X . Role of vaccination in the sustainability of healthcare systems. J Mark Access Health Policy. 2016; 3. PMC: 4802702. DOI: 10.3402/jmahp.v3.27043. View